Arginase activity and magnesium levels in blood of children with diabetes mellitus

Journal of Basic and Clinical Physiology and Pharmacology

Volumn 20, Issue 4, 2009, Pages 319-334

  Bjelakovic, G ^a   Sokolovic, D ^a   Kocic, G ^a   Jevtovic, T ^a   Stojanovic, I ^a   Pavlovic, D ^a   Nikolic J ^a   Basic, J ^a   Ljiljana, S ^b   llic, M ^b   Bjelakovic, Lj ^b   Zivic, S ^b  

^a Intitute of Biochemistry   (Serbia)

^b UNIVERSITY OF NI   (Serbia)

Author keywords

arginase; childhood; diabetes mellitus type 1; magnesium (Mg2+)

Indexed keywords

ARGINASE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; MAGNESIUM ION;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HORMONE ACTION; HUMAN; HYPERGLYCEMIA; MAGNESIUM BLOOD LEVEL; MALE; PRESCHOOL CHILD; PROTEIN DEGRADATION; SCHOOL CHILD;

ADOLESCENT; ARGINASE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS; ENDOTHELIAL CELLS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MAGNESIUM; MALE; NITRIC OXIDE;

EID: 76049089687     PISSN: 07926855     EISSN: 21910286     Source Type: Journal    
DOI: 10.1515/JBCPP.2009.20.4.319     Document Type: Article

References (60)

1. Harris, RA, Crabb, DW. Metabolic Interrelationships. In: Devlin TM (ed), Textbook of Biochemistry with clinical correlations, Wiley-Liss, New York, 1997:525-62.
2. King, MW. The medical biochemisty page. Actions of insulin. Available at: httD://web.indstate.edu/thcme/mwking/diabetes.html Last modified; November 21, 2008.
3. Bowen, R. Pathophysiology of endocrine system. Fundamental concepts in endocrinology. Physiologic effects of insulin. Available at: rbowen@colostate.edu. Last updated on November 11,2007.
4. Li, H, Meininger, CJ, Kelly, KA, Hawker, JR, Morris, SM, Wu, G. Activities of arginase I and II are limiting for endothelial cell proliferation. Am J Physiol Regul Integr Comp Physiol 2002; 282: R64-9.
5. Bachetti, T, Comini, L, Francolini, G, Bastianon, D, Valetti, B, Cadei, M, et al. Arginase pathway in human endothelial cells in pathophysiological conditions. J Mol Cell Cardiol 2004; 37(2):515-23.
6. Li, H, Meininger, CJ, Hawker, JR, Haynes, TE, Kepka-Lenhart, D, Mistry, SY, et al. Regulatory role of arginase I and II in nitric oxide, polyamine, and proline synthesis in endothelial cells. Am J Physiol Endocrinol Metab 2001;280:E 75–82.
7. Cederbaum, SD, Yu, H, Grody, WW, Kem, RM,Yoo, P, Iyer, RK. Arginases I and II: do their functions overlap? Mol Genet Metab 2004;81:S 38–44.
8. Durante, W, Liao, L, Reyna, SV, Kelly, J, Peyton, KJ, Schafer, AI. Physiological cyclic stretch directs L-arginine transport and metabolism to collagen synthesis in vascular smooth muscle. FASEB J 2000;14:1775-83.
9. Meijer, AJ, Lamers, WH, Chamuleau, RA. Nitrogen metabolism and Ornithine cycle function. Physiol Rev 1990; 70(3):701-48.
10. thEd., WH Freeman Co, New York, 2004.
11. 2+accumulation by insulin in rat hearts and cardiac ventricular myocytes. Circ Res 2000;86:326-33.
12. Saris, NE, Mervaala, E, Karppanen, H, Khawaja, JA, Lewenstam, A. Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta 2000;294:1–26
13. 2+homeostasis and uptake in rat liver cells. Am J Physiol Endocrinol Metab 2004;286:E184-93.
14. Porembska, Z, Kedra, M. Early diagnosis of myocardial infarction by arginase activity determination Clin Chim Acta 1975;60(3):355-61.
15. Prior, RL, Smith, SB. Role of insulin in regulating amino acid metabolism in normal and alloxan-diabetic cattle. J Nutr 1983;113(5): 1016-31.
16. Ash, DE. Supplement: Arginine metabolism: enzymology, nutrition, and clinical significance. Structure and function of arginases. J Nutr 2004;134:2760S-4S.
17. Meijer, AJ, Lamers, WH, Chamuleau, RA. Nitrogen metabolism and ornithine cycle function. Physiol Rev 1990;70(3):701-48.
18. Yu, H, Yoo, PK, Aguirre, CC, Tsoa, RW, Kem, RM, Grody, WW, et al. Widespread expression of arginase 1 in mouse tissues: biochemical and physiological implications. J Histochem Cytochem 2003;51:1151-60.
19. Kashyap, SR, Lara, A, Zhang, R, Park, YM, DeFronzo, RA. Insulin reduces arginase activity in type 2 diabetes. Diabetes Care Epub 2007 Oct 10.
20. Kashyap, SR, Abigail, Lara A., Renliang, Zhang R., Park, MY, De Fronzo, RA. Insulin reduces plasma arginase activity in type 2 diabetic patients. Diabetes Care 2008;31:134-9.
21. Bond, JS, Faillasv, ML, Unger DF. Elevated manganese concentration and arginase activity in livers of streptozotocin-induced diabetic rats. J Biol Chem 1983;258(13):8004-9.
22. Erisir, M, Ercel, E, Yilmaz, S, Ozan, S. Evaluation of optimal conditions for arginase activity in streptozotocin induced diabetic rats. Vet Med -Czech 2005;50(2):69–76.
23. Hsueh, WA, Anderson, PW. Hypertension, the endothelial cell, and the vascular complications of diabetes mellitus. Hypertension 1992;20: 253-60.
24. Traub, O, Van Bibber, R. Role of nitric oxide in insulin-dependent diabetes mellitus-related vascular complications. West J Med 1995: 162(5):439-45.
25. Wu, G, Morris, SPERM. Arginine metabolism; nitric oxide and beyond. Biochem J 1998;336:1–17
26. Kepka-Lenhart, D, Mistry, SK, Wu, G, Morris, SM. Arginase I: a limiting factor for nitric oxide and polyamine synthesis by activated macrophages? Am J Physiol Regul Integr Comp Physiol 2000;279: R2237-42.
27. Morris, SM. Arginine metabolism; boundaries of our knowledge. J Nutr 2007;137;1602S-9S.
28. Ignarro, LJ, Buga, GM, Wei, LH, Bauer, PM, Wu, G, del Soldato, P. Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation. Proc Natl Acad Sci 2001;98(7): 4202-8.
29. Yang, Z, Ming, X. Endothelial arginase: a new target in atherosclerosis. Curr Hypertens Rep 2006;8(1):54-9.
30. Durante, W, Johnson, FK, Johnson, RA, Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol 2007;34(9):906-11.
31. Zhang, C, Hein, TW, Wang, W, Chang, Cl, Kuo, L. Constitutive expression of arginase in microvascular endothelial cells counteracts nitric oxide-mediated vasodilatory function. FASEB J 2001;15:1264-6.
32. Berkowitz, DE, White, R, Li, D, Minhas, KM, Cemetich, A, Kim, S, et al. Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation 2003;108:2000-6.
33. Cohen, RA. Special issues in diabetes: nitric oxide and oxidants in diabetic vascular complications. Kardiovaskuläre Medizin 2004; 7:359-61.
34. Santhanam, L, Christianson, DW, Nyhan, D, Berkowitz, DE. Arginase and vascular aging. J Appl Physiol 2008; 105(5): 1632-42.
35. Durante, W. Regulation of L-arginine transport and metabolism in vascular smooth muscle cells. Cell Biochem Biophys 2001;35:19–34.
36. Katusic, ZS. Mechanisms of endothelial dysfunction induced by aging Circ Res 2007;101:640-1.
37. Cosentino, F, Lüscher, TF. Endothelial dysfunction in diabetes mellitus. J Card Pharmacol 1998;32 Suppl 3:S 54–61.
38. Romero, MJ, Platt, HD, Tawfik, HE, Labazi, M, El-Remessy, AB, Bartoli, M, et al. Diabetes-induced coronary vascular dysfunction involves increased arginase activity. Circ Res 2008;102:95–102.
39. Morrison, RF, Seidel, ER. Vascular endothelial cell proliferation: regulation of cellular polyamines. Cardiovasc Res 1995;29(6):841-7
40. Tabor, CW, Tabor, H. polyanimes. Annu Rev Biochem 1984;53:749-90
41. Pegg, AE. Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res 1988;48:759-74.
42. Thomas, T, Thomas, JT. Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell Mol Life Sci 2001;58:244-58.
43. Wallace, HM. Polyamines and their role in human disease—an introduction. Biochem Soc Trans 2003;31:354-5.
44. Bachrach, U. Polyamines and cancer. Amino acids 2004;26:307-9.
45. Gugliucci, A, Menini, T. The polyamines spermine and spermidine protect proteins from structural and functional damage by AGE precursors: a new role for old molecules? Life Sci 2003:72:2603-16.
46. Gugliucci, A. Polyamines as clinical laboratory tools. Clin Chim Acta 2004;344:23–35.
47. Moinard, C, Cynober, L, de Bandt, JP. Polyamines: metabolism and implications in human diseases. Clin Nutr 2005;24(2): 184-97.
48. Méndez, JD, Balderas, FL. Inhibition by L-arginine and spermidine of hemoglobin glycation and lipid peroxidation in rats with induced diabetes. Biomed Pharmacother 2006;60(1):26–31.
49. Hansen, C, Irmscher, AK, Kuhlemann, K, Beyer, J, Kahaly, G. Insulindependent diabetes mellitus and glycosaminoglycans. Horm Metab Res 1995;27(12):555-8.
50. Sales, CH, Pedrosa, LdeF. Magnesium and diabetes mellitus: their relation. Clin Nutr 2006;25(4):554-62.
51. Elamin, A, Tuvemo T Magnesium and insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1990;10(3):203-9.
52. 2-in the regulation of protein synthesis and cell proliferation: Significance for neoplastic transformation. Adv Cancer Res 2005;93:1–58.
53. Rubin, H. The logic of the Membrane, Magnesium, Mitosis (MMM) model for the regulation of animal cell proliferation. Arch Biochem Biophys 2007;458(1): 16–23.
54. Vormann, J. Magnesium: nutrition and metabolism. Mol Aspects Med 2003;24(1-3):27–37.
55. Rosenthal, O, Gottlieb, B, Gorry, JD, Varsinfluence, HM. Influence of cations on the intracellular distribution of rat liver arginase. J Biol Chem 1956;469-78.
56. Terasaki, M, Rubin, H. Evidence that intracellular magnesium is present in cells at a regulatory concentration for protein synthesis. Proc Nat Acad Sci USA 1985;82:7324-6.
57. Gürlek, A, Bayraktar, M, Ozaltin, N. Intracellular magnesium depletion relates to increased urinary magnesium loss in type I diabetes. Horm Metab Res 1998;30(2):99–102.
58. Nourmohammadi, I, Kocheki-Shalmani, I, Shaabani, M, Gohari, L, NazariH.Zinc, copper, chromium, manganese and magnesium levels in serum and hair of insulin-dependent diabetics. J Trace Elem Metabol 2000;2:88–100.
59. White, JR Jr, Campbell, RK. Magnesium and diabetes: a review. Ann Pharmacother 1993; 27(6):775-80.
60. 2+homeostasis and transport in cardiac cells of streptozotocin-injected diabetic rats. J Cell Biochem 2008; 104(3): 1034-53.